Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is a publicly traded Healthcare sector company. As of May 21, 2026, ZNTL trades at $3.59 with a market cap of $258.41M and a P/E ratio of -1.92. ZNTL moved +4.52% today. Year to date, ZNTL is +170.80%; over the trailing twelve months it is +189.84%. Its 52-week range spans $1.01 to $6.95. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces ZNTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ZNTL moved +4.52% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $3.59 |
| Market Cap | $258.41M |
| P/E Ratio | -1.92 |
| EPS | $-1.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.95 |
| 52-Week Low | $1.01 |
| Volume | 52 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-137.06M |
| Gross Margin | 0.00% |
7 analysts cover ZNTL: 0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.